Skip to main content
. 2021 Aug 29;23(4):397–405. doi: 10.22074/cellj.2021.7251

Table 1.

Breast invasive ductal carcinoma patient’s clinicopathological features


Variable n (%)

Age (Y)
<47 44 (48.88)
≥47 46 (51.11)
T stage
T1 ≤2 38 (42.22)
T2 }>2 15 (16.67)
T3 19 (21.11)
T4 18 (20)
Lymph node involvement
Positive 54 (60)
Negative 36 (40)
Metastasis status
Metastatic 30 (33.33)
Non-metastatic 60 (66.67)
Clinical TNM staging
I 30 (33.33)
II and III 30 (33.33)
IV 30 (33.33)

TNM; Tumor, nodes, and metastases.